Effects of sevelamer and calcium on coronary artery calcification in patients new to dialysis: time for better controlled clinical trials.
Qunibi
W Y
WY
D002114:Calcinosis / Q000209:etiology*; D002118:Calcium / Q000009:adverse effects* / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D018849:Controlled Clinical Trials as Topic / Q000706:statistics & numerical data / Q000639:trends; D003324:Coronary Artery Disease / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D018450:Disease Progression; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D028044:Phosphate-Binding Proteins / Q000494:pharmacology; D011073:Polyamines / Q000009:adverse effects* / Q000494:pharmacology; D006435:Renal Dialysis; D015203:Reproducibility of Results; D000069603:Sevelamer
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D028044:Phosphate-Binding Proteins; D011073:Polyamines; D002784:Cholesterol; D000069603:Sevelamer; D002118:Calcium